Inflammation in heart failure: pathophysiology and therapeutic strategies
Jacinthe Boulet(Montreal Heart Institute), Michel White(National and Kapodistrian University of Athens), Jean‐Claude Tardif(Montreal Heart Institute), Nadia Bouabdallaoui(Montreal Heart Institute), Vikas S. Sridhar(University Health Network)
Cited by 129
Related Papers
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k